In the third and final part of this video interview, Sam Liu, VP of marketing, Vivalink looks forward in the BYOD space and forecasts potential advancements for consumer devices.
ACT: Looking forward, what does the future of bring-your-own-device (BYOD) adoption look like?
Liu: I think it's already common. I think you'll see a shift towards using it for more novel or preventive measures to more serious conditions. And so, I think that will gradually grow into that direction as the consumer devices become more and more medical-grade capable. And there's more apps that are also qualified to be medical grade that run on those devices. I think what is a natural progression is that there will be more powerful devices that can actually do more in terms of real diagnostics—potentially even some treatment. So, I see it evolving in that direction.
And I think maybe the other thing is with consumer devices/BYOD, they also allow a larger population to get access to healthcare. From a global standpoint, that's probably the most important thing because we take it for granted here. Or certain countries that have healthcare, or accessible healthcare, but there's a lot of parts of the world that don't really have that. And these consumer devices, maybe that’s their first interaction with healthcare in some places. So I think that's an interesting dynamic.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.